Skip to main content

Advertisement

Table 3 the influence of apoA1 genotypes on Lp(a) based on gender and a) diabetic (non-diabetic (T2DM-) and diabetic (T2DM+)) and b) CVD (without CVD (CVD-) and with established (CVD+)).

From: ApolipoproteinA1-75 G/A (M1-) polymorphism and Lipoprotein(a); Anti- vs. Pro-Atherogenic properties

a)
  Female ApoA-1 genotypes Lp(a) g/l Male ApoA-1 genotypes Lp(a) g/l
  M1 ++ M1 +-/-- P value M1 ++ M1 +-/-- P value
T2DM - 0.260(0.027) 0.312(0.023) <0.05 0.174(0.02) 0.328(0.03) <0.05
T2DM + 0.190(0.018) 0.420(0.038) <0.05 0.146(0.014) 0.149(0.09) NS
b)
  Female ApoA-1 genotypes Lp(a) g/l Male ApoA-1 genotypes Lp(a) g/l
  M1 ++ M1 +-/-- P value M1 ++ M1 +-/-- P value
CVD - 0.198(0.02) 0.374(0.03) <0.05 0.153(0.0.2) 0.246(0.04) <0.05
CVD + 0.273(0.02) 0.320(0.01) NS 0.218(0.02) 0.190(0.018) NS